D
Power Law company profile
D3 Bio
Biotech & Life Sciences · Wuxi, China · Founded 2020 Unicorn
Global footprint
Where D3 Bio has talent and traffic
Web traffic by country
2K
monthly visits
across markets
across markets
🇺🇸 United States100%
Patent intelligence
$9M patent portfolio · 16 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$9M
0.86% of valuation · 7.7× smaller than top peer Neumora Therapeutics ($66M)
16 active patent families
Where D3 Bio innovates
PyrimidineCarcinosisPharmaceutical drugPharmaceutical SubstancesPharmaceutical medicine
Below peer median on Legal, Market
Quality vs same-sector peers
D3 Bio on the five Patsnap quality dimensions
D3 Bio in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where D3 Bio concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across D3 Bio and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee D3 Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.